Ugur Sahin
Chief Executive Officer presso BIONTECH SE
Patrimonio netto: 3 810 M $ in data 31/03/2024
Posizioni attive di Ugur Sahin
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIONTECH SE | Chief Executive Officer | 02/06/2008 | - |
Founder | 02/06/2008 | - | |
reBOOST Management GmbH
reBOOST Management GmbH Miscellaneous Commercial ServicesCommercial Services reBOOST Management GmbH engages in the acquisition, management, and sale of firms. It also offers management and consulting services. The company was founded on August 23, 2018 and is headquartered in Mainz, Germany. | Chief Executive Officer | 23/10/2018 | - |
Medine GmbH
Medine GmbH Miscellaneous Commercial ServicesCommercial Services Medine GmbH engages in the holding of participating interests in firms. It also manages its own assets and provides business consulting services. The company was founded on August 15, 2008 and is headquartered in Mainz, Germany. | Chief Executive Officer | 14/03/2011 | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | 01/01/2014 | - |
Helmholtz Institute For Translational Oncology | Corporate Officer/Principal | - | - |
BioNTech Delivery Technologies GmbH
BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The private company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting. | Chief Executive Officer | - | - |
Storia della carriera di Ugur Sahin
Precedenti posizioni note di Ugur Sahin
Società | Posizione | Inizio | Fine |
---|---|---|---|
TRON - Translationale Onkologie an der Universitätsmedizin der
TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings. | Chief Executive Officer | 01/01/2010 | 01/01/2019 |
Chairman | - | - | |
Founder | 01/01/2010 | 01/01/2019 | |
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Tech/Sci/R&D Officer | 01/01/2001 | 30/07/2010 |
Founder | 05/11/2009 | 30/07/2010 | |
Ci3 Management UG | Founder | - | - |
Formazione di Ugur Sahin
Universität zu Köln | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 11 |
Posizioni
Chief Executive Officer | 5 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Settori
Commercial Services | 5 |
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIONTECH SE | Health Technology |
Aziende private | 8 |
---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
Ci3 Management UG | |
TRON - Translationale Onkologie an der Universitätsmedizin der
TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings. | Commercial Services |
Medine GmbH
Medine GmbH Miscellaneous Commercial ServicesCommercial Services Medine GmbH engages in the holding of participating interests in firms. It also manages its own assets and provides business consulting services. The company was founded on August 15, 2008 and is headquartered in Mainz, Germany. | Commercial Services |
reBOOST Management GmbH
reBOOST Management GmbH Miscellaneous Commercial ServicesCommercial Services reBOOST Management GmbH engages in the acquisition, management, and sale of firms. It also offers management and consulting services. The company was founded on August 23, 2018 and is headquartered in Mainz, Germany. | Commercial Services |
BioNTech Delivery Technologies GmbH
BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Part of BioNTech SE, BioNTech Delivery Technologies GmbH is a German company that engages in research and development of immunotherapies. The private company is based in Halle, Germany. The CEOs of the company are Ugur Sahin, Sierk Poetting. | Commercial Services |
Helmholtz Institute For Translational Oncology |
- Borsa valori
- Insiders
- Ugur Sahin
- Esperienza